Your browser doesn't support javascript.
loading
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability.
Zhang, Lizhou; More, Kunal R; Ojha, Amrita; Jackson, Cody B; Quinlan, Brian D; Li, Hao; He, Wenhui; Farzan, Michael; Pardi, Norbert; Choe, Hyeryun.
Affiliation
  • Zhang L; Division of Infectious Disease, Boston Children's Hospital, Boston, MA, USA. lizhou.zhang@childrens.harvard.edu.
  • More KR; Department of Pediatrics, Harvard Medical School, Boston, MA, USA. lizhou.zhang@childrens.harvard.edu.
  • Ojha A; Department of Immunology and Microbiology, UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL, USA. lizhou.zhang@childrens.harvard.edu.
  • Jackson CB; Department of Immunology and Microbiology, UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL, USA.
  • Quinlan BD; Department of Immunology and Microbiology, UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL, USA.
  • Li H; Division of Infectious Disease, Boston Children's Hospital, Boston, MA, USA.
  • He W; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
  • Farzan M; Department of Immunology and Microbiology, UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL, USA.
  • Pardi N; Department of Immunology and Microbiology, UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL, USA.
  • Choe H; Division of Infectious Disease, Boston Children's Hospital, Boston, MA, USA.
NPJ Vaccines ; 8(1): 156, 2023 Oct 11.
Article in En | MEDLINE | ID: mdl-37821446

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NPJ Vaccines Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NPJ Vaccines Year: 2023 Document type: Article